We are live on ! Find out more
AGL icon

Agilon Health

184 hedge funds and large institutions have $791M invested in Agilon Health in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 61 increasing their positions, 56 reducing their positions, and 58 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more call options, than puts

Call options by funds: $5.23M | Put options by funds: $3.46M

9% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 56

0.15% less ownership

Funds ownership: 4.19%4.04% (-0.15%)

12% less funds holding

Funds holding: 209184 (-25)

36% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 58

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

53% less capital invested

Capital invested by funds: $1.69B → $791M (-$900M)

Holders
184
Holders Change
-25
Holders Change %
-11.96%
% of All Funds
2.42%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
37
Increased
61
Reduced
56
Closed
58
Calls
$5.23M
Puts
$3.46M
Net Calls
+$1.78M
Net Calls Change
-$264K
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
76
New York State Common Retirement Fund
New York
$153K
Handelsbanken Fonder
77
Handelsbanken Fonder
Sweden
$142K +$58.8K +972 +48%
Simplex Trading
78
Simplex Trading
Illinois
$141K +$160K +2,645 +816%
Jane Street
79
Jane Street
New York
$120K -$647K -10,697 -81%
Group One Trading
80
Group One Trading
Illinois
$119K +$97.9K +1,619 +183%
PFSRSONJ
81
Police & Firemen's Retirement System of New Jersey
New Jersey
$118K +$150K +2,481 New
SIC
82
Samalin Investment Counsel
New York
$115K +$116K +1,916 +379%
KK
83
KLP Kapitalforvaltning
Norway
$111K +$141K +2,340 New
N
84
Numerai
California
$108K +$137K +2,269 New
RFP
85
Root Financial Partners
California
$104K
Zurich Cantonal Bank
86
Zurich Cantonal Bank
Switzerland
$104K
YWS
87
Yarger Wealth Strategies
Ohio
$103K -$18.5K -306 -12%
Mariner
88
Mariner
Kansas
$101K -$38.1K -630 -23%
EF
89
Empowered Funds
Pennsylvania
$97.4K +$124K +2,052 New
QC
90
Quadrature Capital
United Kingdom
$89.4K -$46.9K -775 -29%
XT
91
XTX Topco
Cayman Islands
$88.4K -$177K -2,929 -61%
B
92
Bailard
California
$80.1K -$484 -8 -0.5%
Ameriprise
93
Ameriprise
Minnesota
$78.6K +$100K +1,656 New
Mackenzie Financial
94
Mackenzie Financial
Ontario, Canada
$76.9K -$10.4K -172 -10%
Victory Capital Management
95
Victory Capital Management
Texas
$71.3K -$2.24K -37 -2%
DTL
96
Dynamic Technology Lab
Singapore
$70K -$16.4K -272 -16%
Russell Investments Group
97
Russell Investments Group
United Kingdom
$68.7K +$86.1K +1,425 +6,786%
Pictet Asset Management
98
Pictet Asset Management
Switzerland
$68.4K
PAG
99
Private Advisor Group
New Jersey
$67.5K -$7.07K -117 -8%
CAPTRUST Financial Advisors
100
CAPTRUST Financial Advisors
North Carolina
$67.4K +$8.4K +139 +11%

AGL Hedge Fund Activity: Q4 2024 in Review

184 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q4 2024, worth a combined $791M — down 53% from $1.69B a quarter earlier.

Sellers outnumbered buyers: 58 funds closed out of AGL and 37 opened new positions — a net loss of 21 holders — while 56 trimmed existing stakes and 61 added.

The largest buyer was Capital International Investors, adding an estimated $22.6M. The largest seller was Fidelity Investments, cutting an estimated $50.8M.

  • 184 institutional investors held Agilon Health (AGL) as of Q4 2024, down from 209 in Q3 2024.
  • Funds reported $791M of Agilon Health stock for Q4 2024, down 53% quarter-over-quarter.
  • 37 funds opened new Agilon Health positions in Q4 2024 and 58 closed out, a net change of -21 holders.
  • The largest Agilon Health buyer in Q4 2024 was Capital International Investors, an estimated $22.6M added.
  • The largest Agilon Health seller in Q4 2024 was Fidelity Investments, an estimated $50.8M sold.

Based on aggregated 13F filings for Q4 2024.